|
Market Closed -
Nasdaq
16:00:00 2026-10-21 EDT
|
5-day change | 1st Jan Change | ||
| 2.200 USD | -5.98% |
|
-4.35% | -37.32% |
| 10-08 | Rocket Pharmaceuticals Shares Rise After Goldman Sachs Upgrade | MT |
| 10-08 | Goldman Sachs Upgrades Rocket Pharmaceuticals to Neutral From Sell, Price Target is $4 | MT |
| Market Cap | 257M 229M 212M 192M 361M 24.24B 366M 2.54B 997M 12.74B 964M 944M 40.6B | P/E 2026 * |
-8.41x | P/E 2027 * | -1.65x |
|---|---|---|---|---|---|
| Enterprise Value | -63.73M -56.79M -52.57M -47.58M -89.64M -6.01B -90.7M -630M -247M -3.16B -239M -234M -10.07B | EV / Sales 2026 * |
-57.6x | EV / Sales 2027 * | -6.96x |
| Free-Float |
96.82% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RCKT | Delayed | |
CBOE
| RCKT | Real-time | |
|
Tradegate
| 9IP1 | Real-time | |
|
Deutsche Boerse AG
| 9IP1 | Delayed | |
|
Börse Stuttgart
| 9IP1 | Delayed | |
|
Boerse Muenchen
| 9IP1 | Real-time |
Last Transcript: Rocket Pharmaceuticals, Inc.
| 1 day | -5.98% | ||
| 1 week | -4.35% | ||
| Current month | -16.35% | ||
| 1 month | -34.72% | ||
| 3 months | -35.86% | ||
| 6 months | -43.01% | ||
| Current year | -37.32% |
| 1 week | 2.16 |  | 2.4 |
| 1 month | 2.16 | | 3.41 |
| Current year | 2.16 | | 5.45 |
| 1 year | 2.16 | | 5.45 |
| 3 years | 2.16 | | 32.52 |
| 5 years | 2.16 | | 36.87 |
| 10 years | 2.16 | | 67.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gaurav D. Shah
CEO | Chief Executive Officer | 51 | 2018-01-03 |
Martin Wilson
DFI | Director of Finance/CFO | 49 | 2025-09-07 |
Syed Rizvi
CTO | Chief Tech/Sci/R&D Officer | 59 | 2025-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gaurav D. Shah
BRD | Director/Board Member | 51 | 2018-01-03 |
Rod Wong
CHM | Chairman | 49 | 2017-12-31 |
David Southwell
BRD | Director/Board Member | 65 | 2017-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/11/26 | Sell | Chief Financial Officer | -75,364 | 0.0687% | ||
| 8/18/26 | Sell | Chief Executive Officer | -2,293 | 0.0021% | ||
| 8/18/26 | Sell | Chief Financial Officer | -631 | 0.0006% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.98% | -4.35% | -45.00% | -87.18% | 257M | |
| -0.21% | -6.36% | +49.00% | +74.13% | 66.34B | |
| -0.22% | +10.10% | +12.77% | +87.32% | 52.92B | |
| +0.82% | +9.46% | +7.75% | +73.53% | 54.82B | |
| +3.28% | +6.12% | +30.46% | +50.05% | 44.09B | |
| +0.51% | +10.71% | +21.30% | +133.92% | 43.72B | |
| -1.15% | +3.10% | +259.71% | +594.60% | 42.13B | |
| +0.10% | +9.96% | +17.15% | +59.33% | 33.96B | |
| -1.30% | -3.61% | +37.37% | +7.16% | 26.17B | |
| +0.69% | +6.07% | +31.89% | +26.94% | 23.37B | |
| Average | -0.24% | +4.47% | +42.24% | +101.98% | 38.78B | |
| Weighted average by Cap. | +0.43% | +4.67% | +51.22% | +127.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.11M 987K 913K 827K 1.56M 104M 1.58M 10.95M 4.3M 54.92M 4.15M 4.07M 175M | 11.25M 10.02M 9.28M 8.4M 15.82M 1.06B 16.01M 111M 43.65M 558M 42.18M 41.31M 1.78B |
| Net income | -17.91M -15.96M -14.78M -13.37M -25.19M -1.69B -25.49M -177M -69.51M -888M -67.18M -65.79M -2.83B | -183M -163M -151M -137M -258M -17.29B -261M -1.81B -711M -9.09B -687M -673M -28.96B |
| Net Debt | -321M -286M -264M -239M -451M -30.25B -456M -3.17B -1.24B -15.9B -1.2B -1.18B -50.67B | -335M -299M -277M -250M -471M -31.63B -477M -3.32B -1.3B -16.63B -1.26B -1.23B -52.98B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-21 | US$2.200 | -5.98% | 2,022,756 |
| 26-10-20 | US$2.340 | +4.46% | 1,889,490 |
| 26-10-19 | US$2.240 | +2.75% | 1,850,666 |
| 26-10-16 | US$2.180 | -7.63% | 1,969,099 |
| 26-10-15 | US$2.360 | +6.79% | 1,878,872 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RCKT Stock
Select your edition
All financial news and data tailored to specific country editions
